5 minute read
Jan. 8, 2024

Billion-Dollar Molecules: M4 Modulators, GLP1 Biased Agonists, and an SSTR2 Radiotherapy

Author:  
Editor:  

Last December, the pharmaceutical industry witnessed many important updates for clinical molecules, ranging from neurology-based therapies to anti-tumors and radiopharmaceuticals, in addition to the unfortunate discontinuations. In case you missed it, here is a recap of the most notable news updates in the pharma world for December 2023

Loading...

twitterlinkedinemail

Other articles you may be interested in